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Genome integrityNon-coding RNAs (ncRNAs) are increasingly recognized as central players in diverse biological pro-
cesses. Upon DNA damage, the DNA damage response (DDR) elicits a complex signaling cascade,
which includes the induction of multiple ncRNA species. Recent studies indicate that DNA-damage
induced ncRNAs contribute to regulation of cell cycle, apoptosis and DNA repair, and thus play a key
role in maintaining genome stability. This review summarizes the emerging role of ncRNAs in DNA
damage and repair.
Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
1.1. DNA damage and repair
Genomes continually face the challenge of DNA damage caused
by environmental and endogenous insults. To combat the potential
adverse effects from DNA damage cells have developed a sophisti-
cated signaling cascade to sense and repair DNA damage and main-
tain genome integrity. Depending on the source of damage, DNA
may experience a wide variety of lesions such as modiﬁcation of
bases, single strand breaks (SSBs), or double strand breaks (DSBs)
[1,2].
Repair of DNA lesions by the DDR pathway comprises three ma-
jor steps: (i) detection of damage by sensors, (ii) recruitment of re-
pair factors to sites of damage by signal transducers and (iii) repair
by effectors [3]. Repair of different types of DNA damage is carried
out by speciﬁc repair pathways: DNA mismatches are corrected by
mismatch repair (MMR), whereas chemical modiﬁcations of DNA
bases are repaired by base excision repair (BER) [4,5]; the nucleo-
tide excision repair (NER) pathway corrects more complex lesions
such as pyrimidine dimers and intrastrand crosslinks [6,7], and
SSBs are repaired by single-strand break repair (SSBR) [8]; DSBs,
which are the most toxic and difﬁcult to repair DNA lesions, arecorrected either by non-homologous end joining (NHEJ) or homol-
ogous recombination (HR). NHEJ occurs primarily during pre-repli-
cative (G0 and G1) phases of the cell cycle and does not require a
template DNA sequence since broken DNA ends are directly re-
joined. On the other hand, HR requires a homologous DNA tem-
plate sequence for error-free repair and predominates in S phase
of the cell cycle. For repair of DSBs by HR, DNA ends are resected
to yield 30 single-strand DNA overhangs and the resected DNA,
with help of HR proteins, permits strand invasion of a partner
homologous sequence to form a nascent D-loop structure [9]. This
is followed by synthesis of DNA by the synthesis-dependent strand
annealing (SDSA) pathway or the double-strand break repair
(DSBR) pathway [9]. Repair of DSBs is mediated by proteins of
the phosphatidylinositol 3-kinase-like protein kinase (PIKKs) fam-
ily, particularly ATM, ATR, and DNA-PKcs, and the choice of repair
pathway is inﬂuenced by type of lesion and the cell cycle phase
[10]. In NHEJ, DSBs are recognized by Ku70–Ku80 heterodimers
leading to activation of DNAPKcs, which then stabilize DSBs
through phosphorylation of the repair protein Artemis, the histone
variant H2AX, and by recruitment of XRCC4/LIG4 ligase complex
for religation of the broken ends with the help of the stimulatory
factor XLF [7]. For repair by HR in S-phase, DSBs are detected by
the MRE11-RAD50-NBS1 (MRN) complex, which promotes the
activation of ATM by autophosphorylation [11]. This is followed
by the rapid phosphorylation by ATM of various DNA repair factors
such as H2AX, CtIP, BRCA1 and exonuclease EXO1 [9].DDR activa-
tion leads to phosphorylation of histone H2AX (cH2AX), which is
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triggers the recruitment of chromatin remodeling- and modiﬁca-
tion-complexes, which allow the association of downstream fac-
tors, such as 53BP1 and BRCA1. 53BP1 is an inhibitor of BRCA1
accumulation at DSB sites in the G1 phase of the cell cycle and
promotes NHEJ, whereas BRCA1 promotes end resection and HR
[12–14]. Single-stranded DNA generated by resection due to the
activities of MRE11, CtIP, EXO-1 and BRCA 1, is rapidly coated by
replication protein A (RPA) and is subsequently replaced by
RAD51 in the presence of BRCA2 [9]. The single-strand ends bound
by repair proteins can subsequently invade the homologous
template to prime DNA synthesis, which copies and restores
genetic information disrupted by the DSB. Although ATM is the
primary responder to DSBs in S-phase, recent evidence suggests
that ATR, which responds to ssDNA and stalled replication forks,
is also activated upon ionizing radiation (IR)-induced DSBs in a
cell-cycle dependent manner. ATR activation in response to DSB
occurs during S- and G2-phase of the cell cycle and requires
ATM, MRN and CtIP [15,16].
In response to damage and activation of the DDR, cells may un-
dergo cell cycle arrest until repair is complete or, if the damage is
irreparable, cells undergo apoptosis or move into senescence.
While the primary response to DNA damage is very fast and
mediated through posttranslational modiﬁcations, such as phos-
phorylation by kinases of the PIKKs family, the decision to induce
cell-cycle arrest or apoptosis is mediated through the slower tran-
scriptional responses largely mediated by p53, which is regulated
by ATM and CHK2 in response to DSBs [17]. Following DSBs, p53
is activated by the ATM kinase through a transcriptional circuit
involving the WIP1 phosphatase and the MDM2 E3 ubiquitin
ligase, which are induced by p53 and negatively regulate ATM
and p53, respectively [18].
The DNA repair process manifests itself in the form of stable
cytological structures called DNA-repair foci, generated by recruit-
ment and accumulation of DNA-repair factors at the site of DNA
damage [19,20]. These foci are intrinsically dynamic in nature
and are formed by the continuous exchange of DNA-repair factors
between the chromatin-bound pool and the freely diffusing nucle-
oplasmic pool at the site of DSBs [19,20]. Details of the structural
organization of repair foci have not been elucidated, but some of
the factors involved in the formation of foci are the sensor complex
MRN, the DDR mediator MDC1, ATM kinase and the downstream
factors c-H2AX, 53BP1 and BRCA1. It is not known whether the
accumulation of repair factors in foci is essential for efﬁcient repair
or is merely a byproduct of the repair process, but it is possible that
they play a key role in the repair process by concentrating essential
factors and/or by keeping the broken ends in spatial proximity,
enhancing the efﬁciency of repair [19]. Chromatin modiﬁcations
and remodeling events, most prominently the phosphorylation of
H2AX, around the DNA lesions are thought to contribute to the
ﬁne-tuning of damage signaling and repair [19,21–23]. In order
to facilitate repair and checkpoint signaling, chromatin undergoes
rapid local and global decondensation in response to DNA damage
[24,25]. Apart from phosphorylation of the C-terminal tail of H2AX,
several modiﬁcations of multiple core histones through acetyla-
tion, methylation, ubiquitination and phosphorylation, have been
linked to various aspects of DNA damage and repair [19,22,26].
1.2. Non-coding RNAs (ncRNAs)
During the last decade our understanding of genome organiza-
tion has signiﬁcantly increased and it has been recognized that
large stretches of once assumed non-transcribed intergenic regions
in fact code for a large number of non-coding transcripts [27–30].
Non-coding RNAs are generally deﬁned as RNA species that do not
have protein coding potential. With the exception of ncRNAs suchas ribosomal RNAs (rRNAs), small nuclear RNAs (snRNAs), small
nucleolar RNAs (snoRNAs), and transfer RNAs (tRNAs), the remain-
ing ncRNAs are arbitrarily grouped into short (<200 nt) and long
(>200 nt) ncRNAs. Short RNAs can be further subdivided into
microRNAs (miRNAs), piwi interacting RNAs (piRNAs) and small
interfering RNAs (siRNAs). Short and long ncRNAs differ in their
origin, processing and mode of action. Increasing evidence suggests
that various ncRNAs play a pivotal role in DDR. This was not unex-
pected, as changes in transcription and chromatin structure that
are an integral part of DDR are also modulated by ncRNAs [31–
33]. This review highlights the emerging roles of ncRNAs in DDR.
1.3. miRNAs
miRNAs are short (19–24 nt), single-stranded ncRNAs that
regulate gene expression at the post-transcriptional level either
by cleavage of target mRNA or by repressing translation [34,35].
miRNAs probably contribute to the regulation of most major gene
pathways as more than half of the human transcriptome is pre-
dicted to be under miRNA regulation [36,37]. miRNAs biogenesis
and maturation is a complex multi-step process and initiates with
their transcription by RNA polymerase II into primary miRNA (pri-
miRNAs) from intergenic or intronic/exonic loci, often during tran-
scription of their host genes. The pri-miRNAs are then cleaved in
the nucleus by the DROSHA-DGCR8 microprocessor to generate
approximately 70-nt long hairpin-shaped precursors called pre-
miRNAs [38]. The transport of pre-miRNAs from the nucleus to
the cytoplasm is mediated by exportin-5, a RanGTP-binding nucle-
ar transporter [39,40]. In the cytoplasm, the RNAse III-like enzyme
DICER and TARBP2 (TAR binding protein 2) cleaves pre-miRNAs
into a transient duplex of around 20–24 nt in size made up of
the functional miRNA strand and the passenger strand [39,40].
The mature miRNA binds to Argonaute (Ago) proteins to form an
miRNA-induced silencing complex termed RISC, which mediates
gene silencing by mRNA degradation or translation inhibition
[41,42]. Target recognition by miRNA generally depends on base-
pairing between miRNA seed sequence (nt 2–8 at the 50 end of
miRNA) and sequences in the 30 UTR of the target mRNA. The
choice of gene silencing by mRNA degradation or translation inhi-
bition appears to be determined by degree and nature of comple-
mentary sites between miRNA and the mRNA target [37,43–45].
Interestingly, it has been recently shown that translational inhibi-
tion precedes mRNA degradation and is necessary for mRNA degra-
dation by miRNAs [46]. Expression and biogenesis of several
miRNAs is affected by DNA damage whereas, in turn, some miRNAs
regulate DNA repair factors (Fig. 1).
1.4. Long non-coding RNAs
Long non-coding RNAs (lncRNAs) are deﬁned as RNA species
longer than 200 nt that do not appear to have protein coding po-
tential [33]. Use of tiling arrays has revealed that a vast majority
of the genome is transcribed and that transcription is not limited
to protein-coding regions, but is instead pervasive and the genome
probably codes for as many, if not more, lncRNAs genes as protein
coding genes [47–50]. lncRNAs have been shown to play functional
roles in numerous biological processes ranging from cell cycle con-
trol and pluripotency, to differentiation and disease. They can act
as both cis- and trans-regulators of gene activity and as modulators
of the epigenome [33,51–53]. lncRNAs have been classiﬁed on the
basis of their position with respect to protein coding genes: (i) anti-
sense lncRNAs arise from the antisense strand of known protein-
coding genes, (ii) intronic lncRNAs are encoded within introns of
protein-coding genes, (iii) long intergenic non-coding RNAs (lincR-
NAs) are transcribed from intergenic regions between protein cod-
ing genes, and (iv) bidirectional lncRNAs that initiate in the
Fig. 1. The complex interplay of ncRNAs and DNA damage. Activation of the DNA damage response (DDR) induces multiple kinds of non-coding RNAs (ncRNAs) such as
microRNAs (miRNAs), DROSHA- and DICER-dependent (ddRNAs), DSB-induced small RNAS (diRNAs), and long intergenic non-coding RNAs (lincRNAs). ATM, BRCA1 and p53
are involved in regulation of miRNA biogenesis. P53 and BRCA1 also regulate miRNA expression. Misregulated miRNAs expression such as in cancer may contribute to direct
inhibition of key proteins in DDR such as ATM, DNAPKcs, H2AX, BRCA1 and p53. DDRNAs produced from sites of DNA damage contribute to formation of DNA repair foci.
diRNAs contribute to HR mediated repair. p53 also induces expression of lincRNAs which modulate gene expression to regulate cell cycle and apoptosis. Activating effects
(green), inhibitory effects (red).
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The molecular mechanisms by which lncRNAs exert their function
is not fully understood, but emerging studies indicate that lncRNAs
associate with proteins in chromatin or ribonucleoprotein com-
plexes and act as signals, decoys, guides or scaffolds for these pro-
tein complexes to execute their activities in the genome [33,54].
Some examples of lncRNA expression in response to DNA damage
have recently emerged (Fig. 1), and will be discussed below.
2. miRNAs in DNA damage
2.1. miRNA expression upon DNA damage
A role for miRNAs in the cellular response to DNA damage is
supported by the fact that knock-down of key miRNA processing
proteins, particularly DICER or Ago2, reduces survival and check-
point response after UV damage and is accompanied by cell-cy-
cle-dependent relocalization of Ago2 into cellular stress granules
[55]. In addition, a large number of miRNAs are transcriptionally
induced upon DNA damage and the level of induction is variable
depending on cell type and the nature and intensity of DNA
damage [55–63].
The transcription of a subset of miRNAs in the DDR is dependent
on the tumor suppressor p53, a well-studied transcription factor
that is activated upon DNA damage and induces growth arrest or
apoptosis. The study of miRNA expression proﬁles in wild-type
and p53 null cells revealed that expression of three miRNAs, miR-
NA-34a, miRNA-34b and miRNA-34c, is precisely correlated withp53 status [64]. Overexpression of miRNA-34a induces apoptosis
and G1 arrest [64–66]. miRNA-34c overexpression suppresses c-
Myc expression and is thought to prevent inappropriate replication
which may promote genomic instability [67]. Induction of miR-34c
also occurs independently of p53 via the alternative ATM-depen-
dent p38MAPK signaling pathway [67]. Apart from the miR-34
family, a p53-dependent upregulation of miRNA-192, miRNA-194
and miRNA-215 upon genotoxic stress also induces cell cycle arrest
[68–71]. Conversely, p53-mediated transcriptional repression of
miRNAs has also been reported. In cells subjected to hypoxia, levels
of the miRNA-17–92 cluster were reduced in cells containing
wild-type p53, but were unchanged in p53-deﬁcient cells [72]
and overexpression of the miRNA-17–92 cluster inhibits hypoxia-
induced apoptosis [72]. Upon irradiation, a decrease in expression
of the let-7a and let-7b family of miRNAs is observed in human and
mice cells [73]. This decrease in expression of let-7a and let-7b
miRNAs is dependent on p53 and ATM [73]. These studies suggest
that regulation of miRNA expression by p53 modulates the cellular
response to DNA damage via regulation of cell cycle checkpoints
and apoptosis. In fact, promoters of a number of components of
the miRNA processing machinery, including Dicer, contain p53 re-
sponse elements, suggesting that they could be direct transcrip-
tional targets of p53 [74]. P53-induced miRNAs also play
regulatory roles in other cancer-associated processes such as
tumorigenesis, metastasis, epithelial-mesenchymal transition and
metabolic adaptation [75,76]. However, it is currently not clear
whether p53-induced miRNAs actually control any genes directly
involved in DNA repair. Multiple physiological stress conditions
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programs, but miRNA expression proﬁles in response to direct acti-
vation of p53 by DNA damage have not been studied in detail.
More studies are required to speciﬁcally identify miRNAs induced
by direct p53 activation upon DNA damage andto elucidate the role
of these miRNAs in regulating proteins important in DDR. In addi-
tion to p53, other proteins in the DNA repair pathway also regulate
miRNA expression. Besides its role in miRNA biogenesis, BRCA1 re-
presses transcription of miRNA-155 [77]. BRCA1 epigenetically re-
presses miRNA-155 expression via its association with the
histone deacetylase HDAC2, which in turn deacetylates histones
H2A and H3 on the miR-155 promoter [77].
2.2. Regulation of miRNA biogenesis by DDR factors
The key DNA repair factors ATM and BRCA1 have been shown to
modulate miRNA biogenesis by phosphorylating and interacting
with components of the DROSHA microprocessor complex
[78,79]. About 25% of the miRNAs induced upon DNA damage de-
pend on ATM for upregulation [79] and ATM speciﬁcally regulates
processing and biogenesis of these miRNAs by phosphorylating
splicing-regulatory protein KSRP without affecting their transcrip-
tion. KSRP is a component of both the DROSHA and DICER com-
plexes and has been previously shown to promote biogenesis of
a subset of miRNAs [80]. KSRP phosphorylation by ATM leads to
enhanced interaction between KSRP and terminal loops of pri-miR-
NAs which in turn allows for increased recruitment of these pri-
miRNAs for processing by DROSHA and DICER[81].
BRCA1 also regulates miRNA biogenesis (Fig. 1). However, un-
like ATM, BRCA1 directly binds to both speciﬁc pri-miRNAs and
DROSHA [78]. BRCA1 binds to speciﬁc pri-miRNAs via its DNA-
binding domain due to its ability to recognize a stem-loop in the
secondary structure of pri-miRNAs [78]. More studies are required
to understand how regulation of miRNA biogenesis by ATM and
BRCA1 contributes to maintenance of genomic stability.
p53 also facilitates the processing of speciﬁc pri-miRNAs into
pre-miRNAs independently of transcription by associating with
DDX5, a component of the DROSHA-DGCR8 microprocessor com-
plex [82]. This association leads to an increase in the levels of the
mature miRNAs, such as miR-16–1, miR-143 and miR-145 [82].
Use of computational approaches to identify molecules that regu-
late miRNA processing also suggest that p53 and its related family
members p63 and p73 regulate components of miRNA processing
[74].
2.3. miRNA regulation of proteins involved in DDR
While some DDR proteins appear to regulate miRNA expression,
miRNAs in turn also inﬂuence DDR protein expression (Fig. 1). Key
DNA repair proteins such as ATM, H2AX and BRCA1 are subjected
to direct inhibition by miRNAs. ATM is targeted by miRNA-421,
miRNA-18a, miRNA 26b, miRNA-101, miRNA-181 and miRNA100
[83–88]. miRNA-421 suppresses ATM expression by targeting
the 30 UTR of the ATM transcript [83]. Ectopic expression of
miR-421 in cells results in increased sensitivity to IR [83,89] and
overexpression of other miRNAs that target ATM also reduces
ATM expression, alters cell cycle checkpoints, and leads to hyper-
sensitivity to IR. Interestingly, apart from ATM, miRNA-101 also
inhibits DNA-PKcs via binding to the 30-UTR of DNA-PKcs
transcripts [87]. These observations suggest a feedback loop
between miRNAs and ATM (Fig. 1).
H2AX, which plays a key role in DNA damage signaling via
phosphorylation of its C-terminus, is a target of miRNA-24 [90].
Up-regulation of miRNA-24 in post-replicative cells reduces
H2AX and thereby renders cells highly vulnerable to DNA damage
[90]. Screening of a library of human miRNA-mimics in osteosar-coma cells revealed several miRNAs that inhibit cH2AX foci forma-
tion [91]. Among them, miR-138 was shown to directly target the
histone H2AX 30-untranslated region, to reduce histone H2AX
expression, and to induce chromosomal instability after DNA dam-
age [91].
BRCA1 is an important player in homologous recombination and
also regulates miRNA processing. BRCA1 is a target of miRNA-182
[92]. Down regulation of miRNA-182 increases BRCA1 protein lev-
els and protects cells from IR-induced cell death [92]. Consistent
with this, overexpression of miRNA-182 reduces BRCA1 protein
levels, impairs homologous recombination-mediated repair, and
renders cells hypersensitive to IR [92]. Pull-down experiments
with synthetic miRNA indicate that apart from BRCA1, miRNA-
182 also targets a set of other genes involved in the DDR pathway
[93]. Interestingly, miRNA-96, which is expressed as a polycis-
tronic transcript with miRNA-182, targets RAD51, which, together
with BRCA1, is involved in homologous recombination [94]. miR-
NA-146a and miRNA-146–5p bind to the same site in the 30UTR
of BRCA1 and down-regulate its expression [95]. In breast tumors,
levels of these miRNAs are inversely correlated with that of the
BRCA1 protein and these miRNAs are overexpressed in triple neg-
ative breast cancers, the most common type of breast cancer in wo-
men with BRCA1 mutations [95]. miRNA-1, a candidate prognostic
marker of prostate cancer and miRNA-1245, a c-myc induced miR-
NA, also regulate DNA repair by targeting BRCA-1 and BRCA-2,
respectively [96,97]. Interestingly, it has been shown that overex-
pression of miR-99a and miR-100, which target SNF2H, a SWI/
SNF chromatin remodeling factor, leads to reduced localization of
BRCA1 and RAD51 to sites of DNA damage [98], suggesting that
miRNA regulation occurs at many steps in the DNA repair and sig-
naling cascade.
Several miRNAs including miR-125b, miR-504, miR-33, miR-
380–5p, miR-1285, miR-30d and miR-25 have also been shown
to downregulate p53 in a context-dependent manner [99–104]. Ec-
topic expression of these miRNAs induced phenotypes that are
associated with the loss of p53.
CU1276 is a miRNA derived from tRNA which was ﬁrst identi-
ﬁed during screening of miRNA expression in human B cells
[105,106]. CU1276 is derived from tRNA, by DICER dependent bio-
genesis and associates with Ago proteins, and represses in a se-
quence-speciﬁc manner transcripts of RPA1, which is a key gene
in DNA replication and repair [106].
Finally, using computational approaches miRNA binding sites
have been found in several DSB sensors with long 30 UTRs such
as NBS1 and Ku80, and they have been predicted to be regulated
by miRNAs, but these predictions have not yet been validated
experimentally [107,108].3. Non-canonical small RNAs in DNA damage response
DNA damage also induces DROSHA- and DICER-dependent
small RNAs called DDRNAs (Fig. 1), which are distinct from the
canonical miRNAs [109]. These transcripts are produced from se-
quences transcribed from the damaged site and control DDR foci
formation in cultured human and mouse cells and in zebraﬁsh
[109]. In support of an active role of DDRNAs inDDR, transient inac-
tivation of DICER or DROSHA in human cells exposed to IR im-
paired formation of pATM-, 53BP1-, and MDC1-foci, but not c-
H2AX foci, without decreasing the level of these proteins, suggest-
ing that DICER and DROSHA RNA products control DDR activation
and act independently from canonical miRNA-mediated repression
of DDR factors [109]. Moreover, RNase A treatment reduces repair
factor foci formation in DNA damaged cells [109]. Interestingly, it
has been shown that 53BP1 associates with RNA and that RNase
A treatment dissociates 53BP1 from IR-induced foci [110]. Further-
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ﬁed from the same cells, but not tRNA, can rapidly restore DDR foci
formation in DNA damaged cells treated with RNase A [109]. Res-
toration of DDR foci upon RNase A inhibition in RNase-treated cells
is prevented by a-amanitin, suggesting that DDR foci stability re-
quires RNA polymerase II-dependent transcription [109]. Use of a
site-speciﬁc chromosomally integrated DNA damage reporter sys-
tem [111] and deep sequencing indicates that DDRNAs originate
from the damaged genomic locus [109].
The production of small RNA species from near the site of DSB
has also been described in Arabidopsis thaliana and these RNAs
have been termed DSB-induced small RNAs (diRNAs) (Fig. 1)
[112]. These diRNAs require the PI3 kinase ATR, RNA polymerase
IV, and DICER-like (DCL) proteins for their biogenesis and they
are recruited by AGO2 to mediate DSB repair [112]. Interestingly,
while diRNAs were generated from sites in the immediate vicinity
of the DNA break in Arabidopsis, deep sequencing in human cells
revealed that diRNAs are generated from sense- and antisense-
strands within a 5 kb region of the damage site [112]. These diR-
NAs appear to regulate HR mediated repair of DSBs in Arabidopsis
and humans [112].
Induction of small RNAs upon DNA damage seems to be con-
served across species, such as the production small RNAs termed
qiRNAs, from the rDNA locus in response to DNA damage in the
fungus Neurospora crassa[113]. The exact function of these qiRNAs
is unclear but Neurospora strains with mutations in any proteins
involved in qiRNA biogenesis show heightened sensitivity to DNA
damage [113]. In Drosophila, analogous to DDRNAs and diRNAs,
transfection of linearised plasmid DNA mimicking DSB ends elicits
induction of small RNAs known as endo-siRNAs [114]. This re-
sponse is speciﬁc to DSBs, depends on Drosophila endo-siRNA fac-
tors such as Dcr-2, and has the capacity to silence transcripts with
homologous sequence in trans[114].
Chowdhury et al. have speculated on the possible roles these
small ncRNAs could serve in DNA repair. They suggest that they
may act (i) as a template for DNA polymerase to ﬁll in for resected
DNA in HR, (ii) as guides for recruiting DNA repair factors or chro-
matin modifying complexes at DSBs, (iii) in siRNA pathways to de-
grade nascent RNA from the damaged loci to prevent its aberrant
expression or (iv) the ncRNA and Ago complex may act as scaffold
for maintaining repair foci [107]. Overall these studies suggest that
small RNAs generated from the site of DSB or the regions ﬂanking a
DSB are important for DSB repair. The precise mechanisms of ac-
tion and function of these ncRNAs remain unclear, additional stud-
ies dissecting the exact molecular and biochemical function of
these unique classes of small RNAs are required.
4. Long non-coding RNA in response to genotoxic stress
The ﬁrst indication that lncRNAs are induced in response to
DNA damage was the identiﬁcation of non-coding, >200 nt, low
copy number, pol II-regulated, polyadenylated, uncapped tran-
scripts generated upstream of the CCND1 promoter in response
to DNA damage [115]. These transcripts were shown to bind to
TLS, an RNA-binding protein that has been suggested to play roles
in DNA repair and is an inhibitor of histone acetyl transferase CBP/
p300 [115,116]. Upon upregulation by DNA damage, these ncRNAs
bind to TLS to activate it and promote its interaction with CBP/
p300 to cause repression of CCND1 transcription, a cell cycle regu-
lator [115].
Subsequently, several p53-dependent lincRNAs induced upon
genotoxic stress were identiﬁed [117]. One of these, lincRNAp21,
has been shown to play an important role in p53-dependent gene
repression [117]. LincRNAp21 is located 15 Kb upstream of the
gene encoding the cell cycle regulator p21. The p53-dependent
transcriptional repression by lincRNA-p21 is mediated throughits physical association with the transcription- and RNA process-
ing-factor hnRNP-K. This interaction is required for proper geno-
mic localization of hnRNP-K at p53-repressed genes [117].
Interestingly, another lncRNA TUG1 is also induced by p53, binds
to PRC2, and has a role in repressing speciﬁc genes involved in
cell-cycle regulation [29].
To identify functional ncRNAs in the promoter region of 56 hu-
man cell-cycle genes, Hung et al. used high resolution tiling arrays
to probe polyadenylated transcripts in response to diverse pertur-
bations including DNA damage [118]. They identiﬁed one lncRNA,
named PANDA (P21 associated ncRNA DNA damage activated),
which is induced in a p53-dependent manner. Similar to lincR-
NAp21, PANDA is located 5 kb upstream of the cell cycle regulator
p21. PANDA interacts with the transcription factor NF-YA to im-
pede induction of pro-apoptotic genes by NF-YA and PANDA knock-
down sensitizes cells to DNA-damage induced apoptosis [118].
Finally, in response to genotoxic agents such as the DSBs-induc-
ers mitomycin C or the topoisomerase II inhibitor doxorubicin,
mammalian cells induce distinct nuclear long ncRNAs [119]. These
lncRNAs are not likely to be transcriptional noise as they are ubiq-
uitously expressed in various human tissues. Speciﬁc functions for
these lncRNAs, however, remain unknown [119].
Given the fact that DNA repair factors like 53BP1, KU80 and
BRCA1 associate with RNA [110,120,121], that certain RNA binding
proteins like RBMX and hRNPU are recruited to sites of DSBs
[122,123] and that the telomeric repeat-containing RNA TERRA
associates with DNA repair proteins [124,125], it is likely that
DNA damage-induced lncRNAs play a role in DDR. As of now, infor-
mation about the function of lncRNAs in DNA damage is only avail-
able for lincRNAp21 and PANDA. lncRNAs may function in various
ways in DDR pathway such as (i) by acting as guides or signals
for recruitment of repair proteins or chromatin modifying com-
plexes to sites of DNA damage, (ii) acting as scaffolds for DNA re-
pair proteins or the chromatin remodeling machinery at the site
of DNA repair foci, (iii) lncRNA may prevent the action of negative
regulators of DNA repair at the site of DNA damage by acting as de-
coys, or (iv) lncRNAs may act as regulators of DNA damage sensi-
tive gene expression programs like lincRNAp21 and PANDA.5. Conclusions and future perspectives
DNA damage leads to the induction of several ncRNA species
(Fig. 1). The majority of studies on ncRNAs in the DNA damage re-
sponse have so far focused on the role of miRNAs. It is evident that
miRNA induction after DNA damage modulates cell cycle progres-
sion and alters the sensitivity of cells to DNA damage by targeting
downstream gene expression. Since different cell types activate
non-overlapping sets of miRNAs upon DNA damage and the miRNA
response varies depending on the nature of the DNA damaging
agent, it is tempting to speculate that different miRNAs play dis-
tinct roles in different repair pathways. The ability of miRNAs to re-
press key DDR factors has been demonstrated. However, most of
these studies have been done in cancer lines and it is not evident
how miRNAs contribute to DNA repair in normal cells and whether
these responses reﬂect cancer-speciﬁc pathways. It will also be
important to examine whether molecules like 53BP1, NBS1 and
Ku 80, which have been predicted to have miRNA binding sites,
are actually regulated by miRNAs in vivo. Further studies are also
required to delineate the role of miRNAs in different repair path-
ways such as BER and NER. Considering the fact that many miRNAs
are late responders in DDR, it is also probable that miRNAs play a
role in repressing DDR proteins after completion of repair.
The recent discovery of DDRNAs and diRNAs [109,112] has
raised several intriguing questions. To start with, the exact origin
of these small RNAs remains unclear. Francia et al. suggest that
V. Sharma, T. Misteli / FEBS Letters 587 (2013) 1832–1839 1837they arise directly from the site of DSBs [109] whereas Wei et al.
suggest that small RNAs are produced from regions around the
DSBs [112]. It remains to be seen what the reason for these differ-
ences is. Furthermore, the observed requirement for RNA polymer-
ase II-dependent transcription for DDR foci stability needs to be
reconciled with the notion that DNA damage inhibits transcription
[126,127]. These observations also raise the important question of
whether DNA repair foci formation mechanisms are different in
transcriptionally silent heterochromatin regions compared to
transcriptionally active euchromatin. It is also not clear whether
these non-canonical small ncRNAs are induced by other kinds of
DNA damage in addition to DSB. Furthermore, it would be impor-
tant to study the localization of these small ncRNAs by FISH.
In addition to the miRNAs and other short ncRNAs, numerous
lncRNAs have been discovered, which are induced upon DNA dam-
age. However, for most of these lncRNAs there is no experimental
evidence available to indicate a functional role in DDR and further
studies are required to evaluate their role in DDR. Since it is now
believed that a large number of intergenic regions are transcribed
into lncRNAs, it is possible that lncRNAs may be the RNA source for
DICER and DROSHA processing of short RNAs required for DNA re-
pair upon DNA damage at these loci.
Efforts are still needed to identify and further characterize addi-
tional ncRNA species involved in DDR. Use of RNA Immunoprecip-
itation followed by high-throughput sequencing (RIP-seq) to
characterize RNA binding properties of repair proteins and chro-
matin complexes important in DNA repair should be a powerful
approach to achieve this goal. Thestudy of ncRNA function in the
cellular response to different types of DNA damage is still in its in-
fancy. But it is already evident that ncRNAs are important players
in maintaining genomic stability. Given the complexity suggested
by the few identiﬁed players to date, it is likely that many addi-
tional DNA damage-relevant ncRNAs with various functions will
be identiﬁed in the near future and will increase our understanding
of mechanisms of maintaining genome stability.Acknowledgements
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